Drug industry better looking at American generic drug markets.

It is highly recommended for the domestic drug industry to explore a systematic strategy as early as possible for the entry of generic drug markets in the United States.

The revised Hatch-Waxman Act that passed through on Dec. 8 last year in the United States seems to be enacted soon, implying a new opportunity for the Korean pharmaceutical industry to get a great generic drug market in the...